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Abstract 
            The goal of this research project was to identify the effect of the timing of enteral nutrition (EN) 
initiation timing on in-hospital mortality, ICU LOS and hospital LOS among patients with septic shock 
requiring norepinephrine. The study design was a cross-sectional analysis of retrospective electronic 
health record data. Patients who had received norepinephrine for septic shock were divided into early 
EN initiation (within 48 hours of ICU admission) and late EN initiation (Greater than or equal to 48 hours 
after ICU admission) groups. 680 subjects were included; 469 in the early group and 211 in the late 
group. Demographics, comorbidities, and acuity were similar between the two groups. ICU and hospital 
LOS (P=.0002, CI 0.7-0.9, P=<.0001, CI 0.59-0.77, respectively) were significantly shorter in the early EN 
group when controlling for demographics, comorbidities, and acuity. Mortality was not significantly 
different between the two groups when controlling for demographics, comorbidities, and acuity. There 
is a need for higher quality research on the subject, but these findings strengthen the argument that EN 
is safe and potentially beneficial for patients with septic shock requiring norepinephrine.  
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Introduction / Project Overview 
 This project, titled “Effect of enteral feeding timing in septic shock patients” is a quasi-
experimental retrospective study which aims to explore the relationship between enteral feeding 
(EN) timing and length of stay (LOS) and mortality in septic shock patients requiring 
norepinephrine. There is a lack of quality data on the subject and clinician practices vary 
considerably (Marik, 2014). In addition to the study itself, the relevant background, literature, 
and guidelines will be discussed.  
Background and Significance 
 Malnutrition is common among critically ill patients and is known to increase morbidity 
and mortality (Khalid, Doshi, & DiGiovine, 2010). For the purposes of this paper, malnutrition 
refers to inadequate provision of energy and nutrients during hospitalization (rather than chronic 
malnutrition as a result of pre-hospital conditions).  Many critically ill patients are unable to 
ingest food due to weakness, mechanical ventilation, or altered level of consciousness (Khalid et 
al., 2010). In this instance, EN is supplied to the gastrointestinal tract via a tube inserted into the 
nose, mouth, or abdomen. The alternative to EN is parenteral nutrition, which is generally not 
recommended due to increased complication rates, such as infection (McClave et al., 2016).  
 In 2014 there were 2.1 million intensive care unit (ICU) admissions in the United States 
(CDC, 2016). A significant portion of those patients were hemodynamically unstable and 
required vasopressors. Vasopressors are medications that cause constriction of the vasculature, 
most often used to treat hypotension.   
 Critical illness induces a catabolic state but EN supplementation in this population is 
associated with decreased morbidity, mortality, and ICU LOS (McClave et al., 2016). However, 
during times of critical illness initiation, EN is often delayed or withheld. For example, in a 
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prospective study of a nurse-driven protocol to increase EN, Sameh, Halawa, Nisar, and Ahmed 
(2007) found that 50% of patients did not receive EN within the first 48 hours of ICU admission, 
yet the causes of the delay in treatment was not explored. Thus, understanding the effects of 
delayed EN administration is important for practice change.  
 Hemodynamically unstable patients requiring vasopressors present unique challenges for 
clinicians. In critically ill patients, EN can maintain the integrity of the gut, which is essential to 
recovery (Zaloga, Roberts, & Marik, 2003). Yet, EN supplementation among patients requiring 
vasopressors remains a controversial topic due to the potential compromise of the bowel by 
vasopressors and no major authority has specific recommendations regarding initiation and 
provision of EN (Patel et al., 2014).  
Controversy and Concerns 
 The safety and benefit of EN in hemodynamically unstable patients requiring 
vasopressors are largely unknown due to a paucity of research and conflicting theories. Some 
clinicians are concerned that vasopressors may increase the incidence of mesenteric ischemia and 
bowel necrosis in patients requiring vasopressors (Yang, Xigjiang, Wenku, & Jieshou, 2014). It 
is known that EN increases gastrointestinal oxygen needs; thus, in theory, patients requiring 
vasopressors and receiving EN would have increased oxygen demands, but decreased delivery, 
potentially leading to ischemia and necrosis (Zaloga et al., 2003). 
 There is also a concern regarding the hemodynamically failing body’s ability to increase 
cardiac output in response to nutrition as compared to a healthy subject. For example, Revelly, 
Tappy, Gersbach, Cayeux, and Chiolero (2001) found that cardiac output increases when EN is 
initiated in patients requiring vasopressors but that systemic blood pressure decreases. This study 
demonstrates that the body’s adaption to EN may be complex, involving both an increase in 
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cardiac output and peripheral shunting, presumably to provide more blood flow to the gut.
 In the absence of high-quality research and/or guidelines, clinicians are given little 
direction on how to approach these patients. The lack of currently available information may 
lead to non-uniform and substandard care for these patients (Marik, 2014).  Although popular 
theories state that EN supplementation may be dangerous (Marik, 2014), there may be an optimal 
delivery method (timing, dose) that may affect mortality and LOS. Recent literature supports this 
claim and suggests that fears may be overstated while considerable benefit may exist (Khalid et 
al., 2010; Lasierra et al., 2015; Patel et al., 2014; Mancl & Munzevich, 2013). It is important to 
explore the potential benefits of this treatment and engage in a realistic analysis of the safety 
concerns. 
Sepsis: a Major Cause of Morbidity and Mortality 
 Sepsis is directly responsible for about 258,000 deaths per year in America and is the 
ninth leading cause of disease-related mortality (CDC, 2015). Sepsis is the most expensive 
condition in the United States, costing an estimated $20 billion in 2011 (NIH, 2015). Moreover, 
septic shock, a more severe form of sepsis carries a mortality of about 50% (Florian, Yende, & 
Angus, 2013). Norepinephrine is recommended as the first-line treatment of hypotension in 
patients with septic shock (Dellinger et al., 2013). However, various vasopressors may 
differentially affect EN tolerance.   
ASPEN and SCCM guidelines 
 The latest guidelines by the American Society of Parenteral and Enteral Nutrition 
(ASPEN) and the Society of Critical Care Medicine (SCCM) were released in February of 2016 
(McClave et al., 2016). Of note, these guidelines recommend initiating EN within 24-48 of 
admission for critically ill patients. This practice is well-accepted and supported by adequate 
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literature (McClave et al., 2016). However, these guidelines and related research have not been 
validated in patients requiring vasopressors (McClave et al., 2016).  
 Special concern is given to patients who are hemodynamically unstable and requiring 
vasopressors. The recommendation is that patients who have hemodynamic compromise or 
instability should have EN withheld until resuscitation is complete and/or the patient is stable 
(not requiring vasopressors). Cautious initiation of EN may begin when vasopressor support is 
being weaned (titrated down) (McClave et al., 2016). However, the exact timing of EN initiation 
in patients requiring vasopressors is an area of much debate. Khalid, et al. (2010) observed that 
early initiation of EN (within 48 hours of admission) as compared to late initiation of EN (after 
48 hours) was significantly associated with decreased mortality in the ICU (22.5% vs. 28.3%, 
p=.03). The ASPEN and SCCM guidelines acknowledge this finding but do not specifically 
endorse this practice (McClave et al., 2016), likely due to the lack of strong evidence. 
Relevant Literature 
Search Description 
 A comprehensive search of PubMed, MEDLINE, Cochrane, EBSCOhost and CINAHL 
databases was performed. Search terms were: enteric feed(s), enteric feeding, enteral feeding, 
enteric nutrition, enteral nutrition, nutrition, nutritional support, feeding, tube feeding, 
hemodynamic failure, hemodynamic instability, unstable, vasopressors, and vasoactive. The 
timeframe for the search was January 2000 through February 2016. Inclusion criteria were: adult 
subjects (age greater than or equal to 18), patients requiring vasopressors (Norepinephrine, 
epinephrine, dopamine, phenylephrine and vasopressin) and concurrent EN, articles published in 
English and human subjects. Exclusion criteria were: pediatric patients (under age 18), animal 
subjects, meta-analysis, case reports, studies in any language other than English, non-
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differentiation between patients requiring vasopressors and those not, patients not receiving 
vasopressors and EN concurrently, and studies published before 2000. After reviewing titles and 
abstracts of 42 articles, six articles met the inclusion criteria of which three were retrospective 
studies (Khalid et al., 2010; Patel et al., 2014; Mancl & Munzevich, 2013), two prospective 
observational studies (Lasierra et al., 2015; Berger, Revelley, Cayeux, & Chiolero, 2004) and 
one was a prospective cohort interventional study (Revelly et al., 2001).     
  A search for septic patients requiring norepinephrine was first attempted without result. 
Therefore, critically ill patients requiring vasopressors (a broader population) was reviewed.  
The Evidence 
 There are common themes in the topic of EN supplementation in patients requiring 
vasopressors and findings are mostly homogenous; it appears to be safe and potentially 
beneficial. Appendix A contains a summary of all relevant research, with additional related 
articles that did not fit the criteria of the literature review.   
 Safety 
 First and foremost, one must consider the safety of EN supplementation in patients 
requiring vasopressors. The available evidence available strongly suggests that EN 
supplementation is relatively safe with a very low rate of complications. Additionally, in 
critically ill patients serious gastrointestinal (GI) complications may not be directly attributed to 
vasopressor use. Marik (2014) states that the fear of GI complications is often falsely assumed to 
be high. 
 Five studies (Lasierra et al., 2013; Revelly et al., 2001; Mancl & Muzevich, 2013; Patel 
et al., 2014; Berger et al., 2004) reported the occurrence of serious or life-threatening GI 
complications (such as bowel perforation or ischemia). Combined there were 441 patients 
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represented and three instances of serious GI complications. Furthermore, there were several 
confounding variables among the patients who experienced GI complications, such as initiating 
EN at an inappropriately high rate (greater than 20ml/hr) (Mancl & Muzevich, 2013). In a study 
by Steerfkerk, Beishuizen, and Groenveld (2014) a 500 milliliter EN bolus was given to patients 
requiring vasopressors (agents used not specified) without serious GI complications or 
measureable GI ischemia. 
 Lasierra et al. (2015) demonstrated that EN supplementation may be safe in patients with 
severe hemodynamic failure. The subjects in this study required mechanical circulatory support, 
mechanical ventilation, and at least two vasopressors (dopamine, epinephrine, or 
norepinephrine). Despite the severity of illness, these patients received EN without any serious 
complications, such as mesenteric ischemia. Furthermore, the authors found that minor GI 
complications (such as nausea and diarrhea) did not affect mortality.  
 Ability to physiologically adapt to EN supplementation  
 There are concerns about the body’s ability to increase GI blood flow and absorb 
nutrients in patients requiring intravenous vasopressors to treat shock. However, Revelley et al., 
(2000) found that EN supplementation was associated with a favorable hemodynamic response 
in cardiac shock patients requiring vasopressors. Cardiac output and splanchnic perfusion 
increased with EN supplementation, representing an appropriate physiologic response.  
 Timing of EN initiation  
 Timing of EN initiation in patients requiring vasopressors is an area of much debate. 
Khalid et al., (2010) observed that early initiation of EN (within 48 hours of admission) was 
associated with decreased mortality compared to late initiation of EN (after 48 hours). The 
difference was pronounced, with 22.5% ICU mortality in the early EN group and 28.3% ICU 
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mortality in the late EN group (p=.03). This study suggests that early initiation of EN, even 
during hemodynamic instability reduces mortality. The greatest mortality benefit was seen in 
those requiring two or more vasopressors (OR=.36, 95% CI; Khalid et al., 2010).    
 Dose of EN supplementation  
 The dose of EN provided to critically ill patients requiring vasopressors is also an area of 
controversy. “Trophic” EN refers to a practice of permissive underfeeding (Marik, 2014), usually 
between 10-20milliliters (ml) per hour of EN. Patel et al. (2014) examined the effect of 
withholding EN, trophic EN, or full EN to patients requiring vasopressors and mechanical 
ventilation. Mortality was not significantly different among groups, however LOS and duration 
of mechanical ventilation were. The trophic EN group had the lowest median LOS (p<.001) and 
the shortest duration of mechanical ventilation (p<.001). Furthermore, there were no instances of 
aspiration pneumonia in the trophic EN group, whereas the no EN and full groups experienced 
6.7% and 7.2%, respectively (Patel et al., 2014). Overall, this study suggests that trophic EN may 
be the optimal dose for patients requiring vasopressors.   
 Dose of vasopressor  
 The dose of vasopressor may also have in predicting tolerance of EN. Mancl and 
Muzevich (2013) found that there is a dose-dependent relationship between vasopressors and EN 
tolerance (defined as absence of gastric residuals less than 300ml, emesis, positive abdominal 
imaging, or bowel ischemia/perforation). The authors found that above a 12.5mcg/min 
“norepinephrine equivalency” EN intolerance is very likely (p=.009). The authors provide a table 
detailing the calculation for each vasopressors equivalency. This information may be useful in 
stratifying a patient’s risk of EN intolerance based on vasopressor infusion doses.   
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Type of vasopressor  
 A common theme among the research was that certain types of vasopressors are more 
likely to cause EN intolerance than others. Mancl and Muzevich (2013) found that vasopressin 
and dobutamine were associated with EN intolerance while phenylephrine alone did not cause 
EN intolerance. Berger et al., (2004) concluded that norepinephrine and dopamine were 
associated with feeding intolerance to a greater degree than dobutamine.  
Appraisal of Evidence 
 Overall the evidence supporting EN supplementation in patients requiring vasopressors is 
weak. There are no randomized controlled trials represented in the review. This is reflected in the 
weak recommendation (Grade E) provided by the Society of Critical Care Medicine and 
American Society of Parenteral and Enteral Nutrition to withhold EN in hemodynamically 
unstable patients (McClave et al., 2016).  
 The studies included in the review also lack power due to small sample sizes which 
impacts ability to generalize. Overall the review included 1615 subjects. Four of the six studies 
(Lasierra et al., 2015; Revelly et al., 2001; Patel et al., 2014; Berger et al., 2004) had less than 
100 subjects. Most of the research did not specify the diagnoses and/or demographics of the 
subjects. This is a major limitation; as the safety and benefit of EN supplementation may vary 
among populations.  
 The themes listed above are limited by lack of raw data available in each study report. 
For example, not all of the authors provided data on when EN supplementation was initiated. 
Based on the study by Khalid et al., (2010) timing may be an important variable but the authors 
did not specify type or dose of vasopressor. Likewise, Mancl and Muzevich (2013) identified 
dose and type of vasopressor as a variable associated with EN tolerance but did not provide data 
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on timing. Ideally, more data would have been provided by each study so that the author could 
have examined data to validate themes across studies.  
  The strength of the available research is that the findings are mostly congruent and in 
agreement with one another. Expert opinion on the subject (see Appendix A), while based mostly 
on clinical experience is also consistent. All of the available research suggests that EN 
supplementation is likely safe and beneficial in patients requiring vasopressors. Unpublished 
research was not included in this review.  
Selection of Timing as a Variable to Examine 
 There are a plethora of potential variables that may affect the administration of EN in 
patients requiring vasopressors, as evidenced above. Timing was chosen as the variable to be 
studied because it represents a potentially modifiable variable that could affect the outcome of 
patients. Dose of EN was not studied as information on titration and dose of EN are not readily 
available at the institution being studied.  
Objectives 
 The goal of this research project was to identify the effect of the timing of EN 
supplementation on in-hospital ICU LOS, hospital LOS, and mortality in patients diagnosed with 
septic shock requiring norepinephrine (levophed). Specific objectives are as follows: 
1.) Explore the relationship between EN initiation timing and ICU LOS in septic shock 
patients requiring norepinephrine. 
2.) Explore the relationship between EN initiation timing and hospital LOS in septic shock 
patients requiring norepinephrine. 
3.) Explore the relationship between EN initiation timing and in-hospital mortality in septic 
shock patients requiring norepinephrine. 
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4.) Explore the relationship between demographic data (gender/age) and mortality, ICU 
LOS, and hospital LOS.                  
Methods 
Study Design 
 The study was a cross-sectional analysis of retrospective medical record data from 
patients at the University of Kentucky Medical Center. Institutional review board approval was 
obtained on August 10, 2016. Data were electronically collected by the University of Kentucky’s 
Center for Clinical and Translational Science department.  
 Patients were divided into “early” (EN initiation less than 48 hours after ICU admission) 
and late (EN initiation greater than 48 hours after ICU admission) for data analysis. A total of 
469 patients were in the early EN group and a total of 211 were in the late EN group.  
Population 
 The sample for this study was 680 patients that were admitted and discharged (or 
deceased) from the University of Kentucky’s Chandler Hospital. Data were collected from 
January 1, 2005 to July 31, 2015 on patients who were: between 18 and 89 years of age, required 
norepinephrine within 48 hours of admission to the ICU with a diagnosis of “SIRS, sepsis, 
severe sepsis, or septic shock,” and received EN supplementation during ICU stay.   
 Exclusion criteria were: Age less than 18 years or greater than 89 years, not requiring 
norepinephrine within 48 hours of admission, not having been supplied EN during ICU stay, 
death or transfer within 48 hours of admission. 
Variables Collected  
 ICU LOS, hospital LOS, outcome (deceased or alive) age (in 10 year increments), 
gender, Charlson Comorbidity Index (CCI), and Sequential Organ Failure Assessment (SOFA) 
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score were collected for each patient. CCI was used to control for chronic (pre-hospital) 
conditions and SOFA was used to control for acuity.  
Definition of Variables 
 Diagnosis of septic shock was obtained by including patients who were diagnosed with 
systemic inflammatory response syndrome (SIRS), sepsis, severe sepsis, or septic shock and 
prescribed norepinephrine during ICU stay. EN initiation time was obtained by collecting the 
time of order entry for any tube feeding supplement at any rate. Mortality was obtained by 
coding patients with a “notification of death” during their hospital stay as deceased. ICU LOS 
was obtained from electronic chart and included all ICU days during an admission. Hospital LOS 
was obtained from the patients EHR and included all hospital days during an admission.  
 SOFA Score 
 SOFA scores were calculated using the earliest recorded lab values after ICU admission. 
Oxygen requirements, vasopressor doses, Glasgow coma scale, and mean arterial pressure were 
calculated with the highest score (points on scale) while in the ICU. 
 The SOFA score was originally developed to predict the outcome of SIRS patients. It is 
often used as an acuity indicator. It assigns a score to six categories based upon 
normalcy/dysfunction: respiration, coagulation, liver, cardiovascular, central nervous system and 
renal (See Appendix B). A higher score indicates increasing organ failure (Vincent et al., 1996). 
The SOFA score has been validated and is well-accepted for patients on the SIRS/ sepsis 
continuum (Jones, Trzeciak, & Kline, 2009).  
 CCI 
 CCI scores were calculated upon hospital admission, based on previous chronic 
conditions. The CCI is frequently used to quantify chronic, comorbid conditions in critically ill 
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patients.  It was originally designed to predict one-year patient mortality by calculating 
morbidity. The index accounts for 18 broad conditions with varying point allotment; a higher 
score indicates more chronic conditions (See Appendix C). It is an accepted and well validated 
scale (Needham, Scales, Laupacis, & Pronovost 2005).  
Statistical Analysis 
 Age differences between the early and late EN groups were compared using the Mann-
Whitney U test, sex was compared using the Chi-square test, and CCI and SOFA were compared 
using t-tests.  The Mann-Whitney U test was used to compare the early and late EN groups’ ICU 
LOS and hospital LOS. The Chi-square test was used to compare mortality between the early and 
late EN initiation groups.  
 ICU LOS and hospital LOS log-transformed to adjust for the non-normal distribution of 
the original data. Multiple linear regression was performed to assess whether or not EN initiation 
timing (early vs late) was predictive of ICU and Hospital LOS while controlling for age, sex, 
CCI, and SOFA scores.  
Results 
 Demographics, CCI and SOFA scores were similar between the early and late EN groups 
(see Table 1). There was no significant difference between any variable except sex; a higher 
proportion of females were in the late EN group (p=.043). 98.9% of patients (673) were 
mechanically ventilated.  
 ICU LOS and hospital LOS were significantly shorter in the early EN group (p=<.001 for 
both comparisons). The median ICU LOS for the early EN group was 9.3 days compared to 12.7 
days for the late EN group. The median hospital LOS for the early EN group was 14.6 days, 
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compared to 21.6 days for the late EN group (see Table 2).There was no significant relationship 
between EN initiation and mortality (p=.68). 
 The overall linear regression model for ICU LOS was significant (F =5.96 ; R2=.09, 
p<.001). The geometric mean, as opposed to the log-transformed mean (in Table 3) is interpreted 
in this section. ICU LOS was significantly shorter in the early EN group (p=<.001) when 
controlling for age, sex, CCI and SOFA scores (see Table 3). The early EN group had an average 
of 20% fewer ICU days than those in the late EN group. Sex was a significant predictor of ICU 
LOS (p=.013). Females had a 15% average increase in ICU days compared to males. There was 
a significant association between ICU LOS and CCI (p=<.001). For every one-point increase in 
CCI, there was an additional 5% increase in ICU days; a five-point increase was associated with 
an average of 30% increase in ICU days. There was also a significant association between SOFA 
scores and ICU LOS (p=<.001). For every one-point increase in SOFA there was an additional 
5% ICU days; a five-point increase added 15% to ICU days. There was no association between 
age and ICU LOS.  
 The overall linear regression model for hospital LOS was significant (F =6.49 ; R2=0.10, 
p<.001  ). Hospital LOS was significantly shorter in the early EN group (p<.001) when 
controlling for age, sex, CCI and SOFA scores. The early EN group had an average of 33% 
fewer hospital days than the late EN group. There was also a significant association between age 
and hospital LOS (p=.007). Those aged 18-19 had an average of 61% shorter hospital LOS 
(p=<.001). There was a significant association between CCI and hospital LOS (p<.001). For 
every one point increase in CCI, there was an average of 6% increase in hospital days; a five-
point increase was associated with an additional 33% hospital days. There was no significant 
association between sex or SOFA and hospital LOS.  
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 Overall logistic regression was significant (X 2 =67.8, p<.001). Hospital mortality was 
not statistically different between the early and late EN groups, controlling for age, sex, CCI, and 
SOFA score (see Table 4). There was a significant association between age and hospital 
mortality (p=.002). Younger subjects were less likely to experience death than older subjects. 
SOFA score had a significant association with hospital mortality (p<.001); those with higher 
SOFA scores were more likely to experience mortality. Sex and CCI were not associated with 
hospital mortality.  
Report Conclusion 
 The findings of the study demonstrate that ICU and hospital LOS may be reduced by 
initiating EN within 48 hours of ICU admission for patients in septic shock. The difference 
between the median ICU days for early and late EN was 3.4 ICU days Given that there was no 
significant difference between CCI or SOFA scores among the early and late EN groups, the 
mean differences in ICU days between groups cannot be attributed to those factors. However, in 
the multiple linear regression model the R2 value of 0.09 and 0.10 indicates that the variables 
collected in this study poorly controlled for ICU and hospital LOS. A similar study examined 
patients on vasopressors exclusively and found no difference in ICU LOS between those 
supplied with EN early (before 48 hours) or late (after 48 hours) of mechanical ventilation 
initiation (Khalid et al., 2010).  
 Possible confounding variables include dose of provider/nursing care, pre-ICU care 
quality and total pre-ICU time. It is possible that patients who were ordered EN earlier also 
received higher quality provider and/or nursing care. For example, patients who were fed earlier 
may have also been more likely to receive standardized sepsis care in accordance to evidence-
 16 
 
based bundles or guidelines. However, pre-ICU care quality and pre-ICU time are difficult to 
measure and were not included in this study.  
  Hospital LOS was also lower in the early EN group. The difference between the median 
among the two groups was seven hospital days. As previously discussed, the linear regression 
model demonstrated that there were other confounding variables contributing to LOS. The 
hypothesized confounding variables (dose of provider/nursing care, pre-ICU care quality, and 
total pre-ICU time) are similar for hospital and ICU LOS.  
 Early EN initiation may result in increased efficiency and decreased cost when compared 
to late EN initiation. In this study, there were 3.4 greater ICU days in the late versus early EN 
group. The cost of an ICU day is between $3,496 and $10,794 (Dasta, McLaughlin, Moody, & 
Piech, 2005). That represents a cost saving of between $11,886 and $36,699 per patient for ICU 
care. Furthermore, the median hospital days were seven days shorter in the early EN group. The 
cost of a non-ICU day is between $1,470 and $1,716 in Kentucky (Kaiser Family Foundation, 
2016). This represents a cost saving of between $10,290 and $12,012 per patient. Additionally 
this opens hospital beds (both ICU and non-ICU) so that other patients may receive care.  
 There was no association between EN initiation and hospital mortality, even when 
controlling for sex, age, CCI and SOFA scores. This finding differs from that of Khalid et al. 
(2010) who found that a mortality benefit was realized for patient who were supplied with EN 
within 48 hours of mechanical ventilation (p=.03). However, Khalid et al.’s (2010) study was 
larger (n=1174) and included patients in various types of shock, whereas this study only included 
septic shock patients. Furthermore, Khalid et al.’s (2010) study began the 48 hours at time of 
mechanical ventilation, as opposed to time of ICU admission this study.  
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 The results of this study are best interpreted in the context of previous research. To the 
author’s knowledge, there is no study demonstrating an increase in mortality when providing EN 
to patients on vasopressors. However, one study has found a mortality benefit (Khalid et al., 
2010). Patel et al (2014) found that LOS was decreased among patients requiring vasopressors 
when supplied EN. The LOS benefit represents significant cost-saving and efficiency potential.  
Limitations 
 This study has several key limitations. First, the nature of the study (observational, 
retrospective) is an inherent limitation. The timespan of this study, which was approximately 10 
years, is also significant. There may have been changes in both medical education and practice 
relating to sepsis treatment and EN initiation / timing practices. The definition of septic shock 
used in this study may have also captured some patients who were not truly in septic shock.  
Implications for Practice and Research 
 Due to the sample size and limitations listed above, there is no practice change 
recommended at this time. However, this study does add to the pool of evidence stating that early 
EN initiation for patients requiring vasopressors is likely safe and beneficial. Furthermore, this 
study demonstrates that there is a need for high quality research on the subject. There are several 
retrospective studies on the subject; a prospective randomized controlled trial would best control 
for the confounding variables and give providers the evidence needed for a practice change. 
 Ideally, future research would include all of the variables discussed above: type of 
vasopressor, dose of vasopressor, patient diagnosis, EN initiation timing, and EN 
supplementation dose. There is currently one study titled “A randomized controlled trial of 
enteral nutrition in septic shock,” which is currently recruiting subjects (U.S. National Institutes 
of Health, 2016). 
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Conclusions 
 In conclusion, this study found that early EN supplementation may decrease ICU and 
hospital LOS, but did not affect mortality. There are several variables such as dose of EN, dose 
of vasopressor, and additional types of vasopressors required which represent identified 
confounding variables not accounted for in this study. There is no practice change recommended 
at this time based upon the findings of this study and a review of the relevant literature. A 
randomized controlled trial which comprehensively accounts for all known confounding 
variables is necessary to drive practice change. 
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Table 1 
Demographic characteristics of the study sample and comparison by feeding (N=680) 
 Early (n =469 ) 
 
Late (n =211) 
 
p 
Age 
18-19 
20-29 
30-39 
40-49 
50-59 
60-69 
70-79 
80-89    
 
2 (0.4%) 
21 (4.5%) 
41 (8.7%) 
63 (13.4%) 
124 (26.4%) 
121 (25.8%) 
72 (15.4%) 
25 (5.3%) 
 
0 (0%) 
7 (3.3%) 
18 (8.5%) 
37 (17.5%) 
53 (25.1%) 
56 (26.5%) 
30 (14.2%) 
10 (4.7%) 
.73 
Sex 
   Male 
   Female 
 
246 (52.5%) 
223 (47.5%) 
 
 93 (44%)  
118 (56%) 
.043 
CCI Mean=5.1 
Standard Deviation=2.06 
Mean=5.04 
Standard Deviation=2.28 
.71 
SOFA score Mean=9.0 
Standard Deviation=4.0 
Mean=8.96 
Standard Deviation=4.37 
.89 
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Table 2 
Comparison of outcomes (N=680) 
 Early (n =469 ) 
Median (IQR) 
or n (%) 
Late (n =211) 
Median (IQR) 
or n (%) 
 
p 
ICU LOS 9.3 (5.8 – 16.0) 12.7 (6.9-19.9) <.001 
Hospital LOS 14.6 (8.8-25.5) 21.6 (13.6-40.5) <.001 
Mortality 
   Yes 
   No 
 
143 (30.5%) 
326 (69.51%) 
 
61 (28.9%) 
150 (71.09) 
.68 
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Table 3 
Multiple linear regression modeling LOS (N=680)  
 ICU LOS 
(R2 =0.09 , F =5.96 , p = <.001) 
Hospital LOS 
(R2 = 0.10, F =6.49, p = <.001) 
estimate CI p estimate CI p 
Age 
18-19 
20-29 
30-39 
40-49 
50-59 
60-69 
70-79 
80-89 
 
-.8 
.37 
.24 
.08 
.12 
.15 
.13 
ref 
 
.16-1.13 
1.01-2.07 
.95-1.73 
.82-1.43 
.87-1.46 
.9-1.51 
.87-1.5 
.7 
 
 
 
 
 
 
 
 
 
.94 
.71 
.17 
.24 
.2 
.23 
.14 
ref 
 
.13-1.17 
1.38-3.02 
.85-1.65 
.94-1.71 
.92-1.62 
.95-1.66 
.85-1.55 
 
.007 
.09 
<.001 
.32 
.12 
.16 
.12 
.36 
 
Sex 
   Female 
   Male 
 
.14 
ref 
 
1.03-1.28 
 
.013 
 
-.02 
ref 
 
.87-1.09 
 
.70 
CCI .05 1.03-1.08 <.001 .06 1.03-1.09 <.001 
SOFA .03 1.06-1.04 <.001 .003 .99-1.02 .72 
Feeding 
   Early 
   Late 
 
-.022 
ref 
 
.7-.9 
 
<.001 
 
-.39 
ref 
 
.59-.77 
 
<.001 
*This analysis uses the log-transformed versions of the LOS variables to adjust for the non-normal distribution of the original data. Data 
described in text are in actual days format.  
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Table 4 
Multiple logistic regression modeling hospital mortality (N= 651, Chi-square=67.8, p<.001) 
 Odds Ratio CI for OR p 
Age 
18-19 
20-29 
30-39 
40-49 
50-59 
60-69 
70-79 
80-89 
 
1.44 
.09 
.28 
.26 
.26 
.39 
.56 
Reference  
 
.07-28.03 
.02-.37 
.109-.72 
.109-.6 
.118-.58 
.179-.84 
.25-1.27 
.002 
.81 
<.001 
.008 
.002 
<.001 
.02 
.17 
 
Sex 
 
1.02 .71-1.45 .92 
CCI 1.02 .94-1.11 .6 
SOFA 1.19 1.13-1.25 <.0001 
EN initiation  
early 
late 
 
.9 
Reference 
 
.61-1.32 
.59 
*SOFA score calculated with n=448 in early EN group and n=203 in late EN group. 29 Subjects without necessary data to calculate the SOFA 
score.  
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Appendix A: Comprehensive Literature Review Table  
Author/
Year 
Publishe
d 
Concep
tual 
Frame
work 
Design/ 
Method 
Sample/ 
Setting 
Variabl
es  
Measure
ments 
Data 
Analysis 
Findings Level 
of 
Evide
nce 
Quality 
of 
Evidence
/ 
Implicati
ons/ 
Commen
ts 
Enteral nutrition in critically ill patients with severe hemodynamic failure after cardiopulmonary bypass 
Berger 
M, 
Revelly 
JP, 
Cholero 
R.  
 
2005  
 
None 
utilized
. 
Quantitat
ive, 
prospecti
ve, 
observati
onal. 
 
Followed 
70 
patients 
as EN 
was 
begun 
and 
advanced 
to goal 
over 5 
days. 
70 
Patients 
requiring 
ECMO 
with 
cardiovas
cular 
failure. 
 
 
Indepen
dent 
variable
s:  
route of 
nutritio
nal 
support, 
vasopre
ssor 
use. 
 
Depend
ent 
variable
s:  
Total 
energy 
delivery 
from all 
routes. 
 
  
 
 
One-way 
ANOVA 
used to 
compare 
patient 
variables 
and two-
way 
ANOVA 
used to 
compare 
changes 
over 
time.  
Dopamine 
use 
negatively 
related 
with daily 
enteral 
energy 
delivery 
(p=.03, F 
ratio=4.69
). 
 
Norepinep
hrine use 
negatively 
associated 
with daily 
enteral 
energy 
delivery 
(P=.0003, 
F 
ratio=8.96
). 
 
Dobutami
ne use 
negatively 
associated 
with daily 
enteral 
energy 
delivery 
(P=.09, F 
ratio=2.82
). 
Norepinep
hrine and 
dopamine 
were 
associated 
with 
intoleranc
e to goal 
feed, but 
partial 
feeds were 
possible. 
 
Dobutami
ne was 
slightly 
associated 
with 
decreased 
feeding 
tolerance. 
 
There 
were no 
recorded 
incidences 
of serious 
GI 
complicati
ons. 
4 This 
study 
strengthe
ns the 
argumen
t that 
caution 
must be 
used 
when 
feeding 
on 
vasopres
sors and 
inotropes
, but 
evidence
s it can 
be done 
to some 
degree 
safely. 
 
The 
study 
examine
d 
patients 
on 
ECMO, 
which is 
a very 
specific 
subset of 
patients. 
 
The 
study did 
not 
examine 
ICU/Hos
pital 
mortality
 28 
 
, ICU 
days or 
any 
variable 
other 
than 
feeding 
tolerabili
ty to 
goal 
feeds. 
 
Early enteral nutrition and outcomes of critically ill patients treated with vasopressors and mechanical ventilation 
Khalid I., Doshi P., 
DiGiovine B.  
 
2010 
 
Non
e 
utili
zed. 
Quantitati
ve 
Retrospec
tive 
analysis.  
 
Examined 
effect of 
EN 
timing on 
ICU and 
hospital 
mortality. 
1174 
mechan
ically 
ventilat
ed ICU 
patients 
on one 
or more 
vasopre
ssor.   
 
 
Independe
nt 
variables: 
Early vs 
late 
initiation 
of EN 
(within 48 
hours or 
after). 
Number of 
vasopress
ors used. 
 
Dependent 
variables: 
ICU 
mortality, 
hospital 
mortality, 
occurrenc
e of VAP, 
ICU 
length of 
stay, 
vasopress
or-free 
days and 
ventilator-
free days. 
t-test 
used 
for 
normall
y 
continu
ous 
variabl
es, 
kruskal
-Wallis 
test for 
non-
normall
y 
distribu
ted 
data, 
X^2 
test for 
dichoto
mous 
data, 
Kaplan
-Meier 
surviva
l 
analysi
s to 
analyze 
impact 
of early 
feeding 
on 
mortali
ty, and 
log-
rank 
test to 
compar
e time 
Early 
enteral 
ICU 
mortalit
y=22.5 
vs late 
enteral= 
28.3 
(p=.03). 
 
Early 
enteral 
hospital 
mortalit
y=34% 
vs late 
enteral=
44% 
(p=<.00
1). 
 
After 
correctin
g for 
confoun
ders, 
using 
Cox 
proporti
onal 
hazard 
analysis 
early 
enteral 
associate
d with 
30-25% 
decrease
d risk of 
death. 
 
Decreased 
hospital 
and ICU 
mortality 
in patients 
fed 
earlier, 
more 
evident in 
patients 
requiring 
more 2 or 
more 
vasopress
ors. 
4 This 
speaks to 
the benefit 
of early 
feeding, 
but leaves 
many 
questions: 
How 
much 
feeding? 
How fast 
to 
advance? 
Which 
formula?  
 
This may 
indicate 
that the 
benefit of 
early 
feeds 
outweighs 
the risk as 
evidenced 
by the 
decreased 
overall 
mortality. 
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from 
mechan
ical 
ventilat
ion to 
death.  
On 
multiple 
vasopres
sors, 
benefit 
of early 
EN more 
evident 
(OR=.36
, 95% 
CI) 
 
 
Early enteral nutrition in patients with hemodynamic failure following cardiac surgery 
Lasierra J., Perez-
vela J., Makikado 
L., Sanchez E., 
Gomez L., 
Rodriguez B., 
Lopez P., Camara 
A., Gonzalez J.  
 
2015 
 
Non
e 
utili
zed. 
Quantitati
ve, 
Prospecti
ve 
observati
onal. 
 
Examined 
patients 
with 
hemodyn
amic 
failure 
examinin
g 
primarily 
the safety 
of EN. 
37 
post-
cardiac 
surgery 
patients 
on 2 or 
more 
vasopre
ssors 
and/or 
mechan
ical 
circulat
ory 
support 
and at 
least 24 
hours 
of 
mechan
ical 
ventilat
ion and 
receivi
ng EN.   
Independe
nt: 
Hemodyn
amic 
failure 
 
Dependent
:  
EN safety.  
Fisher 
exact 
test 
used 
for 
qualitat
ive 
variabl
es in 
conting
ency 
table, 
Wilcox
on-
Mann-
Whitne
y test 
or 
student 
t test 
used to 
compar
e 
ordinal 
or 
continu
ous 
distribu
tions. 
EN 
related 
complic
ations 
observed 
in 62% 
of 
patients.  
 
No 
instance
s of 
serious 
or life-
threateni
ng 
complic
ations.  
 
No 
significa
nt 
differenc
e in 
mortalit
y 
between 
those 
with and 
without 
EN 
complic
ations. 
No 
significant 
safety 
events in 
hemodyna
mic 
failure 
patients 
receiving 
EN. 
  
No cases 
of 
mesenteri
c ischemia 
noted. 
 
4 This study 
exhibits 
that 
feeding on 
vasopress
ors may 
be safe in 
this 
population
. 
 
The study 
does not 
differentia
te 
between 
type of 
vasopress
or or dose.  
 
Some 
patients 
were 
suppleme
nted with 
parenteral 
nutrition, 
may 
represent 
a 
confoundi
ng 
variable.  
. 
 
Tolerability and safety of enteral nutrition in critically ill patients receiving intravenous vasopressor therapy  
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Mancl 
E.E., 
Muzev
ich 
K.M.  
 
2013  
 
None 
utiliz
ed. 
Quantitat
ive 
Retrospe
ctive 
analysis. 
 
Patients 
examined 
for 
evidence 
of enteric 
feeding 
tolerabilit
y with 
concurre
nt 
vasopress
or use. 
259 
adult 
ICU 
patients 
and 346 
occasion
s of tube 
feeding 
and 
vasopres
sors 
concurre
nt use.  
Independ
ent: 
Type of 
vasopres
sor used, 
dose of 
vasopres
sor used, 
use of 
pro-
motility 
agents. 
 
Depende
nt:  
EN 
tolerance 
(see 
article 
for 
definitio
n), 
mortality 
rates. 
X^2 test 
of 
independe
nce for 
nominal 
data, 
fisher 
exact test 
for 
continuou
s data, 
Brown-
Forsythe 
test for 
unequal 
variances, 
Welch’s 
analysis 
for 
heterogen
eous 
unequal 
variances, 
multi-
variances 
logical 
regression 
for 
independe
nt 
predictors 
of 
reduced 
EN 
tolerance.  
Dose-
dependent 
relationshi
p 
observed 
between 
norepinep
hrine 
equivalent 
vasopress
or use and 
EN 
tolerance. 
 
Lower 
vasopress
or use for 
those who 
tolerated 
EN (12.5 
vs 19.4 
norepinep
hrine 
equivalent 
mcg/min, 
P=.0009). 
 
EN 
tolerance 
did not 
correlate 
with 
mortality.  
 
Patients 
never 
prescribed 
vasopressi
n more 
likely to 
tolerate 
EN 
(77.9% vs 
58.9%, 
P=.0027). 
 
Patient 
never 
prescribed 
dopamine 
more 
likely to 
tolerate 
EN 
(77.6% vs 
63.8%, 
Risk of 
EN 
intoleranc
e 
increases 
as dose of 
vasopress
or does. 
 
Equivalen
t of 
12.5mcg/
min of 
norepinep
hrine is 
tolerated 
well 
 
3 cases of 
perforated 
bowel 
during 
study. 1 
was on 3 
vasopress
ors, the 
other 2 
were 
started on 
high-dose 
feeds 
initially. 
 
Vasopress
in was 
related to 
highest 
incidence 
of feeding 
intolerabil
ity; 
Dopamine 
was 2
nd
. 
 
Phenyleph
rine was 
associated 
with 
increased 
tolerance. 
 
 
4 This study 
gives us 
some 
indication 
as to when 
the risk EN 
intolerance 
is greatest 
(above 
12.5mcg/mi
n 
norepinephr
ine 
equivalent).  
 
This study 
demonstrate
s that 
vasopressin 
may 
significantly 
decrease the 
ability to  
tolerate EN.  
 
More data is 
needed on 
each 
vasopressor 
in 
individual 
diagnoses 
or settings 
(sepsis, MI, 
etc.) in 
order to 
drive 
practice 
change. 
Much of the 
variability 
in 
medication 
response 
could be 
due to drug 
of choice in 
varying 
settings/dia
gnoses. 
 31 
 
P=.018). 
 
Patient 
who 
received 
phenyleph
rine more 
likely to 
tolerate 
EN (100% 
vs. 73%, 
P=.0023). 
 
Enteral Nutrition in the Critically Ill: Myths and Misconceptions 
 
Marik, P. 
 
2014 
Non
e 
utili
zed. 
Expert 
opinion 
with 
reference
s.  
 
Discusses 
common 
myths 
regarding 
nutrition 
in the 
critically 
ill, 
including 
the topic 
of 
vasopress
ors. 
N/A N/A N/A N/A The 
author 
believes 
that 
vasopress
ors are not 
a 
contraindi
cation to 
EN. 
Furthermo
re, he 
believes 
that this 
common 
myth. He 
cites 
studies 
showing 
benefits of 
EN even 
while 
requiring 
vasopress
ors. 
7 Author 
does not 
directly 
address 
argument 
against 
EN.   
He 
presents 
some 
studies 
that 
utilized 
animal 
models to 
demonstra
te safety.  
  
Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: society of 
critical care medicine (SCCM) and American Society of Parenteral and Enteral Nutrition (A.S.P.E.N.) 
McClave S., 
Taylor B., 
Martindale R., 
Warren M., 
Johnson D., 
Braunschweig C., 
McCarthy M., 
Davanos,E., Rice 
Non
e 
utili
zed. 
Expert/A
uthority 
opinion. 
Use of 
literature 
review 
and 
expert 
n/a n/a n/a  n/a Grade E 
recommen
dation to 
hold EN 
in 
hemodyna
mically 
unstable 
7 Authority 
of subject, 
but 
provides 
very little 
guidance 
on when 
to initiate 
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T., Cresci G., 
Gervasio J., Sacks 
G., Roberts P., 
Compher C., 
opinion 
with 
grading 
scheme 
(A-E). 
patient. EN on 
hemodyna
mically 
unstable 
patient 
(i.e., those 
requiring 
vasopress
ors). 
 
Early trophic enteral nutrition is associated with improved outcomes in mechanically ventilated patients with septic 
shock: a retrospective review 
Patel, J.J., 
Kozeniecki, M., 
Biesboer, A., 
Peppard, W., Ray, 
A.S., Thomas, S., 
Jacobs, E.R., 
Nanchal, R., & 
Kumar, G.,  
 
2014  
 
Non
e 
utili
zed. 
Quantitati
ve,  
Retrospec
tive 
analysis. 
 
Examined 
effect of 
EN on 
multiple 
patient 
outcome 
variables.  
66 
patients 
in septic 
shock 
requiring 
mechanic
al 
ventilatio
n and 
vasopress
ors. 
Indepen
dent: No 
EN, 
trophic 
EN, full 
EN,  
 
Depende
nt:  
Duration 
of 
mechani
cal 
ventilati
on, 
aspiratio
n 
pneumo
nia rates, 
EN-
specific 
complic
ations, 
length of 
stay, in-
hospital 
mortalit
y. 
Catego
rical 
variabl
es 
compar
ed with 
chi-
square 
test 
with 
Bonferr
oni 
correcti
on. 
Kruska
l-
Wallis 
test for 
table 1, 
which 
contain
s log 
transfor
med 
duratio
n of 
mechan
ical 
ventilat
ion and 
length 
of stay. 
Multiple 
vasopres
sors 
used in 
40% of 
no EN, 
13.5% 
of 
trophic 
EN and 
21.4% 
of full 
EN.  
 
In-
hospital 
mortalit
y was 
33.3% in 
no EN, 
21.6% in 
trophic 
EN and 
21.4% in 
full EN 
(P=.64). 
 
Length 
of stay 
was 12 
days in 
no EN, 5 
in 
trophic 
EN and 
13 in 
full EN 
(P=<.00
1). 
 
Duration 
of 
mechani
Multiple 
vasopress
ors used 
least in 
the 
trophic 
group, 
could 
represent 
a 
confoundi
ng 
variable.  
 
Mortality 
lowest in 
trophic 
EN, but 
not 
statisticall
y 
significant
.  
 
Length of 
stay 
shortest in 
trophic 
EN.  
 
Duration 
of 
mechanica
l 
ventilation 
lowest in 
trophic 
EN group.  
 
No 
instances 
of 
aspiration 
4 Multiple 
vasopress
or use 
least in 
trophic 
group, 
concernin
g that this 
may 
represent 
confoundi
ng 
variable 
(acuity) 
However, 
APACHE 
2 scores 
similar 
among all 
groups.  
 
Shows 
possible 
benefit to 
trophic 
feeds in 
septic 
shock 
patients 
requiring 
vasopress
ors, but 
may not 
be able to 
extrapolat
e to other 
population
s. 
 
Most 
current 
practice 
guidelines 
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cal 
ventilati
on was 
2.41 
times 
longer in 
no EN 
(P=.14) 
and 1.49 
times 
longer in 
full EN 
(P=.004) 
compare
d to 
trophic 
EN.  
 
No 
instance
s of 
aspiratio
n 
pneumo
nia in 
trophic 
EN, 
compare
d to 
6.7% 
and 
7.2% in 
no EN 
and full 
EN, 
respectiv
ely.  
 
No 
instance
s of non-
occlusiv
e 
mesenter
ic 
ischemia 
in any 
group. 
 
 
pneumoni
a in 
trophic 
EN group, 
comparabl
e among 
other 2 
groups.  
 
No life-
threatenin
g 
complicati
ons of EN 
noted.  
advocate 
for no or 
low 
amounts 
of EN for 
hemodyna
mically 
unstable 
patients. 
This gives 
evidence 
that “low” 
or 
“trophic” 
may be 
better than 
no EN.   
Systemic and splanchnic hemodynamic response to early enteral nutrition in postoperative patients treated for 
circulatory compromise 
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Revelly J.P., 
Tappy L., Berger 
M.M., Gersbach 
P., Cayeux C., 
Chiolero R.  
 
2001  
 
Non
e 
utili
zed. 
Quantitati
ve, 
Prospecti
ve.  
 
EN was 
initiated 
and 
multiple 
metabolic 
and 
hemodyn
amic 
measure
ments 
were 
collected 
in the 
fasted 
state and 
after 
enteric 
feeds 
began. 
Nine 
post-op 
cardiac 
surgery 
patients 
requiring 
vasopress
ors 
and/or 
inotropes
.  
Indepen
dent: 
Fasted 
state vs 
fed state. 
 
Depende
nt: 
Cardiac 
index, 
mean 
arterial 
pressure, 
pulmona
ry 
capillary 
wedge 
pressure, 
ICG 
clearanc
e, gastric 
tonometr
y, 
plasma 
glucose/i
nsulin 
and 
plasma 
lactate.  
 
One-
way 
analysi
s of 
varianc
e for 
data 
collecte
d every 
60 
minute
s, 
compar
ed by 
Dunett’
s test.  
Cardiac 
output 
increase
d 
progress
ively 
and was 
statistica
lly 
significa
nt (10% 
greater 
than 
baseline) 
two 
hours 
after EN 
initiation
.   
 
Mean 
arterial 
pressure 
decrease
d by 
11%, 
after EN 
initiation
, but 
returned 
to 
baseline 
within 
300 
minutes.  
 
Pulmona
ry 
capillary 
wedge 
pressure 
remaine
d 
constant.  
 
Insulin 
and 
glucose 
levels 
increase
d after 
EN 
initiation
.  
 
Gastric 
EN 
increases 
CI 
progressiv
ely and 
decreases 
mean 
arterial 
pressure 
transiently
. 
Metabolic 
response 
was not 
impaired 
splanchnic 
blood 
flow 
seemed to 
increase. 
This 
indicates 
that these 
patients 
were able 
to respond 
appropriat
ely to EN 
initiation.  
4 This study 
demonstra
tes that 
small 
amounts 
of enteric 
feeds can 
be well 
tolerated 
in 
hemodyna
mically 
unstable 
post-op 
cardiac 
patients, 
with 
favorable 
increases 
in cardiac 
output and 
splanchnic 
blood 
flow.  
 
It is very 
limited in 
the fact 
that there 
were nine 
participant
s and it 
measured 
five hours. 
  
Despite 
limitations
, indicates 
that at 
least some 
hemodyna
mically 
unstable 
patients 
respond 
favorably 
to EN 
initially. 
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Gastric feeding intolerance is not caused by mucosal ischemia Measured by intragastric air tonometry in the 
critically ill 
 
Steerfker
k, J.,  
Beishuize
n, A., 
Groeneve
ld, J. 
 
2014 
None 
Utiliz
ed 
Intervention
al, 
Non-
randomized
, 
convenienc
e sample. 
 
Patients 
selected 
consecutive
ly based on 
criteria, 
given 
500ml 
bolus of EN 
and 
intolerance 
endpoints 
measured. 
30 
patients, 
all 
critically 
ill 
mechanica
lly 
ventilated, 
most 
requiring 
vasopresso
rs.  
Independe
nt: 500ml 
bolus of 
EN 
 
Dependent
: Gastric 
residual 
volume, 
Mucosal 
PC02. 
Fisher 
exact 
test for 
categoric
al data, 
student t 
test for 
continuo
us data. 
PC02 
gradient 
did not 
change 
after 
feeding 
(p=0.80) 
 
Gastric 
residual 
volume 
did not 
correlate 
with 
increase 
PC02 
gradient 
(p=0.75) 
 
No 
instances 
of 
intoleran
ce in all 
30 
patients.  
 
Bolus 
feedings 
were 
tolerated 
and not 
associated 
with gut 
mucosal 
ischemia 
in patients 
requiring 
vasopresso
rs.  
4 Provides 
some 
evidence 
that EN 
does not 
cause gut 
ischemia 
and that 
vasopress
ors do not 
cause 
feeding 
intoleranc
e. 
 
Many 
limitation
s; most of 
the raw 
data is not 
available 
in the 
article, the 
sample is 
very 
small, and 
data was 
only 
collected 
2 hours 
tonometr
y and 
ICG 
clearanc
e 
indicate 
an 
increase
d 
splanchn
ic blood 
flow 
after EN 
initiation
. 
 
No 
evidence 
of EN 
intoleran
ce noted.  
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post EN 
on one 
occasion. 
Enteral Feeding and Vasoactive Agents: Suggested Guidelines for Clinicians 
 
 
Turza K., 
Krenitsky 
J., 
Sawyer R., 
 
2009 
None 
utilized 
Expert 
opinion 
with 
supporting 
references. 
n/a n/a n/a n/a Propose a 
four-phase 
process for 
initiating EN 
in patients 
requiring 
vasopressors 
based mostly 
on experience 
but some 
research 
integrated. 
 
Acknowledges 
lack of high-
quality 
research on 
the subject. 
 
 
7 Interesting 
proposal of 
four-phase 
EN feeding 
protocol. 
 
Heavy 
emphasis on 
monitoring 
once EN 
begun, theme 
is common in 
several 
articles 
among 
experts.  
 
Recommends 
against any 
EN in 
patients 
requiring 
high-dose 
vasopressors.  
Early enteral nutrition in critically ill Patients with hemodynamic instability: an evidence-based review and practical 
advice 
 
Yang S., 
Xingjiang 
W., 
Wenku 
Yu., 
Jieshou, Li.  
 
2014 
None 
utilized 
Expert 
opinion 
with 
supporting 
references. 
n/a n/a n/a n/a Acknowledges 
that there is a 
gap in 
literature on 
the subject. 
Recommends 
not 
withholding 
EN due to 
probable 
benefit, but 
advocates 
very careful 
monitoring for 
complications.  
7 Echoes 
popular 
sentiment of 
not 
withholding 
EN due to 
lack of 
current 
knowledge.  
 
Chinese 
physicians, 
evidences 
that this 
issue is 
international 
and not 
specific to 
the U.S. 
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EN=Enteral nutrition  
ECMO= extra corporeal membrane oxygenation 
Level of evidence appraisal per Melynk & Fineout-Overholt (2011). 
Level 1 – Systematic review of all relevant randomized controlled trials (RCT) or clinical 
practice guideline based on systematic review of RCT’s.  
Level 2 – One or more RCT 
Level 3 – Controlled trials without randomization 
Level 4 – Cohort and/or control studies 
Level 5 – Systematic review of qualitative or descriptive studies 
Level 6 – Descriptive or qualitative study 
Level 7 – Expert/ authority opinions 
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Appendix B: SOFA Scoring System 
Variable 0 1 2 3 4 
Respiratory:  
Pa02/FI02 
mmhg 
>400 ≤400 ≤300 ≤200 with 
mechanical 
ventilation 
≤100 with 
mechanical 
ventilation 
Coagulation: 
Platelets 
x10^3/µL 
>150 ≤150 ≤100 ≤50 ≤20 
Liver: 
Bilirubin 
mg/dL 
<1.2 1.2-1.9 2.0-5.9 6.0-11.9 >12.0 
Cardiovascular:  
Hypotension 
No 
hypotension 
Mean arterial 
pressure <70 
Dop ≤5 or 
dob any dose 
Dop >5, epi ≤ 
0.1, or norepi 
≤0.1 
Dop >15, epi 
>0.1, or 
norepi >0.1 
Central nervous 
system: 
Glasgow coma 
scale 
15 13-14 10-12 6-9 <6 
Renal: 
Creatinine 
mg/dL or urine 
output mL/day 
<1.2 1.2-1.9 2.0-3.4 3.5-4.9 or 
<500 
>5.0 or <200 
*Norepi=orepinephrine, Dob=dobuatime, dop=dopamine, Epi= epinephrine, FI02= fraction of 
inspited oxygen. 
*Vasopressors/Inotropes are in µg/kg per minute. 
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Appendix C: Charlson comorbidity index 
Assigned Weight    Conditions 
_________________________________________________________________ 
 
 1     Myocardial infarction 
      Congestive heart failure 
      Peripheral vascular disease 
                                                                        Cerebrovascular disease 
      Dementia 
      Chronic obstructive pulmonary disease 
      Connective tissue disease 
      Peptic ulcer disease 
      Mild liver disease 
      Diabetes mellitus (uncomplicated) 
                                                                        Age 50-59 years 
 
 2     Hemiplegia 
      Moderate or severe renal disease 
      Diabetes mellitus with end organ damage 
      Any tumor (without metastases) 
      Leukemia 
      Lymphoma 
                                                                        Age 60-69 years              
 
 3     Moderate or severe liver disease 
                                                                        Age >70 years 
 
 6     Metastatic cancer 
      Acquired immune deficiency syndrome (AIDS) 
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